Compare NVAX & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | DCO |
|---|---|---|
| Founded | 1987 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 1996 | 1995 |
| Metric | NVAX | DCO |
|---|---|---|
| Price | $10.09 | $126.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $11.33 | ★ $150.20 |
| AVG Volume (30 Days) | ★ 4.2M | 148.9K |
| Earning Date | 05-20-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 309.76 | N/A |
| EPS | ★ 2.58 | N/A |
| Revenue | ★ $1,123,479,000.00 | $824,730,000.00 |
| Revenue This Year | N/A | $7.38 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | $3.97 | ★ N/A |
| Revenue Growth | ★ 64.69 | 4.85 |
| 52 Week Low | $5.01 | $51.76 |
| 52 Week High | $11.85 | $140.02 |
| Indicator | NVAX | DCO |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 53.70 |
| Support Level | $7.81 | $88.31 |
| Resistance Level | $10.42 | $128.17 |
| Average True Range (ATR) | 0.73 | 6.00 |
| MACD | -0.02 | -1.09 |
| Stochastic Oscillator | 36.18 | 49.89 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.